Nilrise Pharmaceuticals Private Limited, a active private limited company, was established on 09 January 2014 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51101GJ2014PTC078226. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Jitendrabhai Lalajibhai Lakhani (Managing Director), Hardikkumar Kalubhai Vaghasiya (Director), Hiral Rajeshbhai Patel (Director). It holds ₹2.16 Cr open charges and ₹1.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 706, Signature Ii,Sarkhej Sanand Highway, Sarkhej, Ahmedabad, Ahmedabad, Gujarat, 382210.
U51101GJ2014PTC078226
078226
09 January 2014
₹1.00 M
₹0.40 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nilrise Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendrabhai Lalajibhai Lakhani | Managing Director | 09 Jan 2014 | Current |
| Hardikkumar Kalubhai Vaghasiya | Director | 09 Jan 2014 | Current |
| Hiral Rajeshbhai Patel | Director | 09 Jan 2014 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nilrise Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.6% decrease. The company also saw a substantial fall in profitability, with a 56.36% decrease in profit. The company's net worth Soared by an impressive increase of 16.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nilrise Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹21,649,000.00
₹1,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jun 2022 | Others | ₹1.61 Cr | Open |
| 15 Jul 2021 | Axis Bank Limited | ₹0.70 M | Open |
| 21 Aug 2019 | Axis Bank Limited | ₹4.85 M | Open |
| 13 Jun 2018 | Yes Bank Limited | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Nilrise Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nilrise Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nilrise Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nilrise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Nilrise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
A charge with Others of Rs. 16.10 M registered on 24 Jun 2022 with Charge ID 100618916 was modified on 16 Sep 2022. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 16.10 M with Charge ID 100618916 was registered on 24 Jun 2022. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 0.70 M with Charge ID 100466025 was registered on 15 Jul 2021. was completed.
A charge registered on 13 Jun 2018 via Charge ID 100187835 with Yes Bank Limited was fully satisfied on 20 Sep 2019. was recorded as a recent event.
The CIN of Nilrise Pharmaceuticals Private Limited is U51101GJ2014PTC078226.
Nilrise Pharmaceuticals Private Limited is headquartered at 706, Signature Ii,Sarkhej Sanand Highway, Sarkhej, Ahmedabad, Ahmedabad, Gujarat, 382210.
Nilrise Pharmaceuticals Private Limited was incorporated on 09 January 2014.
The current directors of Nilrise Pharmaceuticals Private Limited are
The primary industry of Nilrise Pharmaceuticals Private Limited is Trade.
Nilrise Pharmaceuticals Private Limited is unlisted.
The authorized capital of Nilrise Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Nilrise Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX